Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

This study is ongoing, but not recruiting participants.

Study NCT00055913 Information provided by National Cancer Institute (NCI)

First Received: March 6, 2003 Last Updated: March 28, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	May 2004 (Final data collection date for primary outcome measure)